Anebulo Pharmaceuticals Q2 EPS $(0.05) Beats $(0.13) Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsNews
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61.54 percent. This is a 44.44 percent increase over losses of $(0.09) per
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61.54 percent. This is a 44.44 percent increase over losses of $(0.09) per share from the same period last year.